Research on the cancer stem cell marker leucine-rich repeat-containing g-protein coupled receptor 5 (LGR5) has shown that its deletion inhibits β-catenin nuclear translocation and downregulates c-myc/cyclin D expression, leading to ΔΨm collapse and apoptosis. This evidence concerns the gene LGR5 and cancer.